DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
CP-461
( DrugBank: - / KEGG DRUG: - )
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
96
クローン病
1
96. クローン病
臨床試験数
:
2,442
/
薬物数
:
1,278
- (
DrugBank
:
248
) /
標的遺伝子数
:
142
-
標的パスウェイ数
:
209
10
50
100
ALL
trials per page:
Showing 1 to 1 of 1 trials
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT00042055
(
ClinicalTrials.gov
)
July 2002
20020700
22/7/2002
20020722
CP-461
for the Treatment of Crohn's Disease
A Phase II Pilot Study of
CP-461
in the Treatment of Moderately to Severely Active Crohn's Disease
Crohn's Disease
Drug:
CP-461
Astellas Pharma Inc
Cell Pathways;OSI Pharmaceuticals
Completed
18 Years
N/A
Both
30
Phase 2
United States